Derek Hicks - Net Worth and Insider Trading
Derek Hicks Net Worth
The estimated net worth of Derek Hicks is at least $577,737 dollars as of 2024-12-01. Derek Hicks is the EVP, Chief Business Officer of Intellia Therapeutics Inc and owns about 36,987 shares of Intellia Therapeutics Inc (NTLA) stock worth over $577,737. Details can be seen in Derek Hicks's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Derek Hicks has not made any transactions after 2024-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Derek Hicks
Derek Hicks Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Derek Hicks owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .
Click here to see the complete history of Derek Hicks’s form 4 insider trades.
Insider Ownership Summary of Derek Hicks
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | EVP & Chief Business Officer |
Derek Hicks Latest Holdings Summary
Derek Hicks currently owns a total of 1 stock. Derek Hicks owns 36,987 shares of Intellia Therapeutics Inc (NTLA) as of January 3, 2024, with a value of $577,737.
Latest Holdings of Derek Hicks
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | 36,987 | 15.62 | 577,737 |
Holding Weightings of Derek Hicks
Derek Hicks Form 4 Trading Tracker
According to the SEC Form 4 filings, Derek Hicks has made a total of 2 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 3,877 shares on January 3, 2024, which brought Derek Hicks around $114,216.
Insider Trading History of Derek Hicks
- 1
Derek Hicks Trading Performance
Derek Hicks Ownership Network
Derek Hicks Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Derek Hicks is the EVP & Chief Business Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and director & President and CEO John M. Leonard .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Derek Hicks made 1 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 3,877. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Derek Hicks Mailing Address
Above is the net worth, insider trading, and ownership report for Derek Hicks. You might contact Derek Hicks via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street Suite 130, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
